Story thread · 2 reports / 2 sources

Pharma Stocks In Focus: Why Indian Healthcare Could Deliver Strong Growth Over 6–12 Months

businesstoday.in · 2hShare

Pharma and healthcare are emerging as key sectors to watch, with multiple growth drivers supporting the industry. Sudip Bandyopadhyay, Market Expert, believes Indian pharma is approaching a major transformation, similar to where Indian IT stood two decades ago. Large companies are moving towards branded and patented products, while CDMO players are benefiting from the China-plus-one strategy as global pharma companies increase sourcing from India. Domestic-focused pharma companies are also seeing strong growth, supported by rising demand. Although valuations are not particularly cheap, the sector offers attractive long-term growth potential. Investors are increasingly looking at pharma as a key opportunity.

First report: Challenge and opportunity in Ireland’s regulatory pharma space — siliconrepublic.com, 1d